Crossmark

Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease

Crossref DOI link: https://doi.org/10.1007/s00296-022-05196-z

Published Online: 2022-08-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suga, Kensuke https://orcid.org/0000-0003-3107-788X
Nishiwaki, Aya

Nakamura, Takayuki https://orcid.org/0000-0001-9096-2796
Kagami, Shin-Ichiro https://orcid.org/0000-0001-9439-8918
License Information

Text and Data Mining valid from 2022-08-30

Version of Record valid from 2022-08-30
More Information

Article History

Received: 14 July 2022

Accepted: 22 August 2022

First Online: 30 August 2022

Declarations

:

: Kensuke Suga, Aya Nishiwaki, Takayuki Nakamura, and Shin-Ichiro Kagami declare that they have no conflict of interest.

Document is current

Any future updates will be listed below